However, a significant difference in CDKN2A was found between T2DM patients and controls in the G1 group by adjusting FPI (p = 0.001) and HOMA-IR (p = 0.005) by the analysis of covariance (ANCOVA). This evidence concerns the gene CDKN2A and type 2 diabetes mellitus.